Table 3.

Effects of mTOR siRNA and cisplatin alone or combined on growth of human ESCC xenograft in nude mice (n = 5).

Group	Animal weight	Tumor volume at beginning1	Tumor volume at termination	Inhibition rate of tumor (%)
Control	20.54 ± 1.23	57.03 ± 10.45	999.28 ± 167.30	—
siRNA	20.52 ± 2.08	43.62 ± 10.85	416.97 ± 38.12*	58.27
cis	20.38 ± 1.42	39.09 ± 2.08	367.91 ± 61.21*	63.18
siRNA + cis	20.66 ± 1.79	46.28 ± 25.56	232.86 ± 54.23*	76.70

¹Tumor volume is expressed as mm³. *P < 0.05, compared to control group.